{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:30:23Z","timestamp":1782473423877,"version":"3.54.5"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Korea Ministry of Education","doi-asserted-by":"publisher","award":["2021R1I1A3058050"],"award-info":[{"award-number":["2021R1I1A3058050"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.neuropharm.2024.110278","type":"journal-article","created":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T00:32:10Z","timestamp":1735086730000},"page":"110278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Inosine exerts dopaminergic neuroprotective effects via mitigation of NLRP3 inflammasome activation"],"prefix":"10.1016","volume":"266","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0395-6521","authenticated-orcid":false,"given":"Shristi","family":"Khanal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7411-5420","authenticated-orcid":false,"given":"Eun-Joo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2298-5320","authenticated-orcid":false,"given":"Chang Jae","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7312-4077","authenticated-orcid":false,"given":"Jaekwang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6937-6135","authenticated-orcid":false,"given":"Dong-Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neuropharm.2024.110278_bib1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12974-023-02830-w","article-title":"Pharmacologic inhibition of NLRP3 reduces the levels of \u03b1-synuclein and protects dopaminergic neurons in a model of Parkinson's disease","volume":"20","author":"Amo-Aparicio","year":"2023","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110278_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/toxsci\/kfy219","article-title":"Inflammasomes: an Emerging mechanism Translating environmental toxicant exposure into neuroinflammation in Parkinson's disease","volume":"166","author":"Anderson","year":"2018","journal-title":"Toxicol. Sci."},{"issue":"15","key":"10.1016\/j.neuropharm.2024.110278_bib3","first-page":"4230","article-title":"Activation of adenosine A3 receptor attenuates progression of osteoarthritis through inhibiting the NLRP3\/caspase-1\/GSDMD induced signalling","volume":"26","author":"Bai","year":"2022"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110278_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10051023","article-title":"Comparison of microglial Morphology and function in primary Cerebellar cell cultures on Collagen and Collagen-Mimetic Hydrogels","volume":"10","author":"Balion","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuropharm.2024.110278_bib76","doi-asserted-by":"crossref","first-page":"12589","DOI":"10.3390\/ijms222212589","article-title":"Leptin induces apoptotic and pyroptotic cell death via NLRP3 inflammasome activation in rat hepatocytes","volume":"22","author":"Baral","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110278_bib5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.0901363","article-title":"Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110278_bib6","first-page":"417","article-title":"Oral inosine persistently elevates plasma antioxidant capacity in Parkinson's disease","volume":"31","author":"Bhattacharyya","year":"2016"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110278_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151569","article-title":"Microglia-Derived cytokines\/Chemokines are involved in the Enhancement of LPS-induced loss of nigrostriatal dopaminergic neurons in DJ-1 Knockout mice","volume":"11","author":"Chien","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110278_bib8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11302-013-9351-x","article-title":"Anti-inflammatory effects of inosine in allergic lung inflammation in mice: evidence for the participation of adenosine A2A and A 3 receptors","volume":"9","author":"da Rocha Lapa","year":"2013","journal-title":"Purinergic Signal."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110278_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166771","article-title":"Inosine attenuates post-stroke neuroinflammation by modulating inflammasome mediated microglial activation and polarization","volume":"1869","author":"Datta","year":"2023","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.neuropharm.2024.110278_bib10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2015.12.034","article-title":"Mechanisms involved in the antinociception induced by spinal administration of inosine or guanine in mice","volume":"772","author":"de Oliveira","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110278_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106371","article-title":"Differential profiles of serum cytokines in Parkinson's disease according to disease duration","volume":"190","author":"Di Lazzaro","year":"2024","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110278_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41401-022-00951-1","article-title":"Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson's disease","volume":"44","author":"Dong","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2024.110278_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120569","article-title":"Inosine attenuates 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats via the activation of the A2AR\/BDNF\/TrKB\/ERK\/CREB signaling pathway","volume":"300","author":"El-Shamarka","year":"2022","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110278_bib14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12974-020-02009-7","article-title":"Adenosine A3 receptor as a novel therapeutic target to reduce secondary events and improve neurocognitive functions following traumatic brain injury","volume":"17","author":"Farr","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"12","key":"10.1016\/j.neuropharm.2024.110278_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028032","article-title":"Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease","volume":"6","author":"Forsyth","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110278_bib16","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"issue":"13","key":"10.1016\/j.neuropharm.2024.110278_bib17","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1182\/blood-2002-11-3624","article-title":"Differential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivo","volume":"102","author":"Gomez","year":"2003","journal-title":"Blood"},{"issue":"465","key":"10.1016\/j.neuropharm.2024.110278_bib18","article-title":"Inflammasome inhibition prevents \u03b1-synuclein pathology and dopaminergic neurodegeneration in mice","volume":"10","author":"Gordon","year":"2018"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110278_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12974-023-02759-0","article-title":"Inflammasome inhibition protects dopaminergic neurons from \u03b1-synuclein pathology in a model of progressive Parkinson's disease","volume":"20","author":"Grotemeyer","year":"2023","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110278_bib20","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1667\/RR3552.1","article-title":"Guanosine and inosine display antioxidant activity, protect DNA in vitro from oxidative damage induced by reactive oxygen species, and serve as radioprotectors in mice","volume":"165","author":"Gudkov","year":"2006","journal-title":"Radiat. Res."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110278_bib21","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/s12264-023-01023-y","article-title":"NLRP3 inflammasome-mediated neuroinflammation and related mitochondrial Impairment in Parkinson's disease","volume":"39","author":"Han","year":"2023","journal-title":"Neurosci. Bull."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110278_bib22","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4049\/jimmunol.164.2.1013","article-title":"Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock","volume":"164","author":"Hask\u00f3","year":"2000","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110278_bib23","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.tips.2004.01.006","article-title":"Immunomodulatory and neuroprotective effects of inosine","volume":"25","author":"Hask\u00f3","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.neuropharm.2024.110278_bib24","doi-asserted-by":"crossref","first-page":"5230","DOI":"10.4049\/jimmunol.1301490","article-title":"Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation","volume":"191","author":"Heid","year":"2013","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110278_bib25","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nri3705","article-title":"Innate immune activation in neurodegenerative disease","volume":"14","author":"Heneka","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110278_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbi.2012.10.001","article-title":"Further characterisation of the LPS model of Parkinson's disease: a comparison of intra-nigral and intra-striatal lipopolysaccharide administration on motor function, microgliosis and nigrostriatal neurodegeneration in the rat","volume":"27","author":"Hoban","year":"2013","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110278_bib27","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.bbrc.2017.10.004","article-title":"Uric acid demonstrates neuroprotective effect on Parkinson's disease mice through Nrf2-ARE signaling pathway","volume":"493","author":"Huang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110278_bib28","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/ijnp\/pyx065","article-title":"NLRP3 inflammasome contributes to lipopolysaccharide-induced Depressive-like Behaviors via Indoleamine 2,3-dioxygenase induction","volume":"20","author":"Jeon","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"s1","key":"10.1016\/j.neuropharm.2024.110278_bib29","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.3233\/JPD-223338","article-title":"Inflammasome activation in Parkinson's disease","volume":"12","author":"Jewell","year":"2022","journal-title":"J. Parkinsons Dis."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110278_bib30","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1007\/s12035-016-9893-3","article-title":"Inosine, an endogenous purine Nucleoside, suppresses immune responses and protects mice from experimental Autoimmune Encephalomyelitis: a role for A2A adenosine receptor","volume":"54","author":"Junqueira","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2024.110278_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2022.04.003","article-title":"Enhancement of blood\u2013brain barrier penetration and the neuroprotective effect of resveratrol","volume":"346","author":"Katila","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.neuropharm.2024.110278_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109652","article-title":"Dopaminergic neuroprotective effects of inosine in MPTP-induced parkinsonian mice via brain-derived neurotrophic factor upregulation","volume":"238","author":"Khanal","year":"2023","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.neuropharm.2024.110278_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.460","article-title":"NLRP3 inflammasome activation by mitochondrial ROS in bronchial epithelial cells is required for allergic inflammation","volume":"5","author":"Kim","year":"2014","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110278_bib34","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","article-title":"Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure","volume":"46","author":"Langston","year":"1999","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110278_bib35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41418-018-0124-5","article-title":"MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration","volume":"26","author":"Lee","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neuropharm.2024.110278_bib36","article-title":"Edaravone plays protective effects on LPS-induced microglia by Switching M1\/M2 Phenotypes and regulating NLRP3 inflammasome activation","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110278_bib37","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/00000658-200204000-00016","article-title":"Inosine exerts a broad range of antiinflammatory effects in a murine model of acute lung injury","volume":"235","author":"Liaudet","year":"2002","journal-title":"Ann. Surg."},{"key":"10.1016\/j.neuropharm.2024.110278_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2024.137897","article-title":"Vitamin C inhibits NLRP3 inflammasome activation and delays the development of age-related hearing loss in male C57BL\/6 mice","volume":"836","author":"Liu","year":"2024","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110278_bib39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","article-title":"LPS\/TLR4 signal transduction pathway","volume":"42","author":"Lu","year":"2008","journal-title":"Cytokine"},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110278_bib40","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1111\/ejn.15637","article-title":"Proteomic dissimilarities of primary microglia and BV2 cells under stimuli","volume":"55","author":"Luan","year":"2022","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110278_bib41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nri.2015.7","article-title":"Converging roles of caspases in inflammasome activation, cell death and innate immunity","volume":"16","author":"Man","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110278_bib42","first-page":"617","article-title":"Anti-inflammatory effects of inosine in human monocytes, neutrophils and epithelial cells in vitro","volume":"8","author":"Marton","year":"2001","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110278_bib43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","article-title":"Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients","volume":"180","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2024.110278_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116585","article-title":"NLRP inflammasome as a key role player in the pathogenesis of environmental toxicants","volume":"231","author":"Moloudizargari","year":"2019","journal-title":"Life Sci."},{"issue":"4 Pt 1","key":"10.1016\/j.neuropharm.2024.110278_bib45","doi-asserted-by":"crossref","first-page":"C799","DOI":"10.1152\/ajpcell.1989.256.4.C799","article-title":"Turnover of adenosine in plasma of human and dog blood","volume":"256","author":"M\u00f6ser","year":"1989","journal-title":"Am. J. Physiol."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110278_bib46","first-page":"1303","article-title":"NLRP3 inflammasome inhibition prevents \u03b1-synuclein pathology by Relieving autophagy dysfunction in Chronic MPTP-treated NLRP3 Knockout mice","volume":"58","author":"Ou","year":"2021"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110278_bib47","first-page":"1411","article-title":"Fyn kinase regulates misfolded \u03b1-synuclein uptake and NLRP3 inflammasome activation in microglia","volume":"216","author":"Panicker","year":"2019"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110278_bib48","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1084\/jem.20182191","article-title":"Fyn kinase regulates misfolded \u03b1-synuclein uptake and NLRP3 inflammasome activation in microglia","volume":"216","author":"Panicker","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neuropharm.2024.110278_bib49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fimmu.2017.00036","article-title":"Canonical and non-canonical activation of NLRP3 inflammasome at the Crossroad between immune tolerance and intestinal inflammation","volume":"8","author":"Pellegrini","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2024.110278_bib50","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jbiotec.2024.03.005","article-title":"Primary microglia cell cultures in translational research: Strengths and limitations","volume":"386","author":"Pesti","year":"2024","journal-title":"J. Biotechnol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110278_bib51","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41531-022-00293-z","article-title":"The potential convergence of NLRP3 inflammasome, potassium, and dopamine mechanisms in Parkinson's disease","volume":"8","author":"Pike","year":"2022","journal-title":"npj Parkinson's Disease"},{"key":"10.1016\/j.neuropharm.2024.110278_bib52","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fphar.2012.00096","article-title":"Imaging of microglia in patients with neurodegenerative disorders","volume":"3","author":"Politis","year":"2012","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110278_bib53","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s10787-018-0476-y","article-title":"Inosine improves cognitive function and decreases aging-induced oxidative stress and neuroinflammation in aged female rats","volume":"26","author":"Ruhal","year":"2018","journal-title":"Inflammopharmacology"},{"issue":"10","key":"10.1016\/j.neuropharm.2024.110278_bib75","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1001\/jama.2021.10207","article-title":"Effect of urate-elevating inosine on early parkinson disease progression: The SURE-PD3 randomized clinical trial","volume":"326","author":"Schwarzschild","year":"2021","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110278_bib54","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/jamaneurol.2013.5528","article-title":"Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial","volume":"71","author":"Schwarzschild","year":"2014","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110278_bib55","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cbpa.2008.08.014","article-title":"Inosine ameliorates the effects of hemin-induced oxidative stress in broilers","volume":"151","author":"Seaman","year":"2008","journal-title":"Comp. Biochem. Physiol. Mol. Integr. Physiol."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110278_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0290532","article-title":"Lobeglitazone inhibits LPS-induced NLRP3 inflammasome activation and inflammation in the liver","volume":"18","author":"Seo","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2024.110278_bib57","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-024-04481-1","article-title":"Correction: Methanolic Extract of Boswellia serrata Gum protects the nigral dopaminergic neurons from Rotenone-induced neurotoxicity","author":"Shadfar","year":"2024","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110278_bib58","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/135245850100700507","article-title":"Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the disease","volume":"7","author":"Spitsin","year":"2001","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110278_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167211","article-title":"Activin A inhibits MPTP and LPS-induced increases in inflammatory cell populations and loss of dopamine neurons in the mouse Midbrain in vivo","volume":"12","author":"Stayte","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110278_bib60","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrn.2016.178","article-title":"Selective neuronal vulnerability in Parkinson disease","volume":"18","author":"Surmeier","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"issue":"24","key":"10.1016\/j.neuropharm.2024.110278_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24244523","article-title":"In vitro anti-inflammatory effects of Phenolic compounds from Moraiolo Virgin olive Oil (MVOO) in brain cells via regulating the TLR4\/NLRP3 Axis","volume":"24","author":"Taticchi","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2024.110278_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054628","article-title":"LPS triggers acute neuroinflammation and Parkinsonism involving NLRP3 inflammasome pathway and mitochondrial CI dysfunction in the rat","volume":"24","author":"Valenzuela-Arzeta","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110278_bib63","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1038\/ncomms4209","article-title":"Activation of the NLRP1b inflammasome independently of ASC-mediated caspase-1 autoproteolysis and speck formation","volume":"5","author":"Van Opdenbosch","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2024.110278_bib64","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41531-018-0061-5","article-title":"NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson's disease","volume":"4","author":"von Herrmann","year":"2018","journal-title":"NPJ Parkinson's disease"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110278_bib65","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jpha.2022.10.002","article-title":"Inosine: a broad-spectrum anti-inflammatory against SARS-CoV-2 infection-induced acute lung injury via suppressing TBK1 phosphorylation","volume":"13","author":"Wang","year":"2023","journal-title":"Journal of Pharmaceutical Analysis"},{"key":"10.1016\/j.neuropharm.2024.110278_bib66","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.intimp.2018.12.019","article-title":"The mechanisms of NLRP3 inflammasome\/pyroptosis activation and their role in Parkinson's disease","volume":"67","author":"Wang","year":"2019","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110278_bib67","first-page":"3299","article-title":"N-acetyl cysteine inhibits the lipopolysaccharide-induced inflammatory response in bone marrow mesenchymal stem cells by suppressing the TXNIP\/NLRP3\/IL-1\u03b2 signaling pathway","volume":"22","author":"Wang","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110278_bib68","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.cellsig.2016.02.010","article-title":"The adenosine metabolite inosine is a functional agonist of the adenosine A2A receptor with a unique signaling bias","volume":"28","author":"Welihinda","year":"2016","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110278_bib69","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s43556-024-00179-x","article-title":"NLRP inflammasomes in health and disease","volume":"5","author":"Xu","year":"2024","journal-title":"Molecular Biomedicine"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110278_bib70","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/mds.26488","article-title":"Cdk5-Dependent activation of neuronal inflammasomes in Parkinson's disease","volume":"31","author":"Zhang","year":"2016","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110278_bib71","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/svn-2018-000196","article-title":"Microglial activation after ischaemic stroke","volume":"4","author":"Zhang","year":"2019","journal-title":"Stroke Vasc Neurol"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110278_bib72","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","article-title":"Inflammasome activation and regulation: toward a better understanding of complex mechanisms","volume":"6","author":"Zheng","year":"2020","journal-title":"Cell Discovery"},{"issue":"41","key":"10.1016\/j.neuropharm.2024.110278_bib73","doi-asserted-by":"crossref","first-page":"14040","DOI":"10.1074\/jbc.RA120.015036","article-title":"Impaired NLRP3 inflammasome activation\/pyroptosis leads to robust inflammatory cell death via caspase-8\/RIPK3 during coronavirus infection","volume":"295","author":"Zheng","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2024.110278_bib74","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13024-016-0094-3","article-title":"MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease","volume":"11","author":"Zhou","year":"2016","journal-title":"Mol. Neurodegener."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824004477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824004477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T21:11:30Z","timestamp":1740345090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390824004477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":76,"alternative-id":["S0028390824004477"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110278","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inosine exerts dopaminergic neuroprotective effects via mitigation of NLRP3 inflammasome activation","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110278","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110278"}}